| Datasets | Validation | ||||
---|---|---|---|---|---|---|
MS (n = 61) | Non-MS (31) | P | MS (n = 11) | Non-MS (n = 3) | P | |
Age (years) | 44.87 ± 15.66 | 42.71 ± 12.00 | 0.466 | 29.73 ± 10.78 | 42.33 ± 11.85 | 0.195 |
Sex (%) | ||||||
 Female | 37 (60.7%) | 19 (61.3%) | 0.953 | 8 (72.7%) | 2 (66.7%) | 0.837 |
 Male | 24 (39.3%) | 12 (38.7%) |  | 3 (27.3%) | 1 (33.3%) |  |
Subtype (%) | ||||||
 RRMS | 32 (52.5%) | – | – | 8 (72.7%) | – | – |
 PPMS | 10 (16.4%) | – |  | 1 (9.1%) | – |  |
 SPMS | 19 (31.1%) | – |  | 2 (18.2%) | – |  |
DMDs (%) | – | – | – | 3 (27.3%) | – | – |
CSF testing | ||||||
 OB (%) | – | – | – | 1 (16.7%) | – | – |
 Antibody (%) (anti-AQP4, MOG, MBP) |  |  |  | 0 (0.0%) |  |  |